N/A
N=175
Participant Satisfaction With the BUILD Mobile Application
Satisfaction, Personal
Bottom Line
View on ClinicalTrials.gov: NCT05948670 ↗Enrolled (actual)
175
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: User Satisfaction as Measured by the Client Satisfaction Questionnaire (CSQ-8) — 23.49; 23.97 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- DISC-MVP (Device); DISC-CON (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Woebot Health
- Primary completion
- Nov 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY User Satisfaction as Measured by the Client Satisfaction Questionnaire (CSQ-8) |
23.49; 23.97 | — |
| SECONDARY User Satisfaction Amongst a Sub-sample of Adults With at Least Mild Symptoms of Depression and/or Anxiety. |
22.95; 23.68 | — |
Summary
This study explores user satisfaction with the BUILD mobile application.
Eligibility Criteria
Inclusion Criteria
- Must be 18+ years of age and older
- Must own or have regular access to a smartphone with a recent operating system installed (Android: OS 8.0 or higher, Apple: iOS 13.0 or higher) with reliable Wi-Fi access or sufficient data plan to engage with assigned treatment condition for the duration of the study
- Must be available and committed to engage with the program and complete assessments for a 2-week duration
- Must be able to read and write in English
- Must have primary residence in the United States
Exclusion Criteria
- Current suicidal ideation with a plan and/or intent or a suicide attempt within the past 12 months
- Previous Woebot use
Data sourced from ClinicalTrials.gov (NCT05948670). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.